Rigel Pharmaceuticals
XNAS: RIGL
Rigel Pharmaceuticals Live Stock Price Today, Share Analysis and Chart
about
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsi...
Read More
38.85
-0.46
(-1.17%)
846.4K
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Rigel Pharmaceuticals is on 09 Sep 2025 for the purpose of H.C. Wainwright 27th Annual Global Investment Conference
See details
Not Eligible
Mid Valuation
Technically Moderately Bullish
Rigel Pharmaceuticals Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..